Literature DB >> 1595344

Complications and side effects during thiopentone therapy in patients with severe head injuries.

W Schalén1, K Messeter, C H Nordström.   

Abstract

This study reports all complications and side effects occurring in 38 patients with severe traumatic brain lesions treated with barbiturate coma because of a dangerous increase in intracranial pressure. The treatment was induced by intravenous infusion of thiopentone (5-11 mg.kg-1) followed by a continuous infusion of 4-8 mg.kg-1.h-1. The subsequent rate of thiopentone infusion was governed by the level of the intracranial pressure with the intention of keeping ICP below 20 mmHg (2.7 kPa). The duration of treatment was 1-15 days. Arterial hypotension occurred in 58%, hypokalemia in 82%, respiratory complications in 76%, infections in 55%, hepatic dysfunction in 87% and renal dysfunction in 47% of the patients. Twenty patients survived. Mortality in 17 patients was caused by an untreatable increase in intracranial pressure. In one patient complications due to barbiturate treatment may have contributed to the fatal outcome. In none of the other cases were the noted complications and side effects associated with any permanent symptoms or dysfunctions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595344     DOI: 10.1111/j.1399-6576.1992.tb03483.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  28 in total

1.  Severe hyperkalemia induced by a short interruption of barbiturate coma.

Authors:  Eleni E Magira; Konstantinos Sakellaridis; Paraskeui Tselioti; Barbara Grammatikopoulou; Athanasios Prekates
Journal:  Intensive Care Med       Date:  2010-11-10       Impact factor: 17.440

Review 2.  Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".

Authors:  Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  The "Lund Concept" for the treatment of severe head trauma--physiological principles and clinical application.

Authors:  Per-Olof Grände
Journal:  Intensive Care Med       Date:  2006-08-02       Impact factor: 17.440

4.  Refractory intracranial hypertension and "second-tier" therapies in traumatic brain injury.

Authors:  Nino Stocchetti; Clelia Zanaboni; Angelo Colombo; Giuseppe Citerio; Luigi Beretta; Laura Ghisoni; Elisa Roncati Zanier; Katia Canavesi
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

5.  Strategies for therapeutic hypometabothermia.

Authors:  Shimin Liu; Jiang-Fan Chen
Journal:  J Exp Stroke Transl Med       Date:  2012-01-01

6.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

7.  Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series.

Authors:  Shin Yi Ng; Ki Jinn Chin; Tong Kiat Kwek
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

8.  Therapeutic targeting of astrocytes after traumatic brain injury.

Authors:  Jessica Shields; Donald E Kimbler; Walid Radwan; Nathan Yanasak; Sangeetha Sukumari-Ramesh; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2011-11-09       Impact factor: 6.829

9.  Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus.

Authors:  Christopher R Newey; Dolora Wisco; Premkumar Nattanmai; Aarti Sarwal
Journal:  Ther Adv Drug Saf       Date:  2016-07-18

10.  Interaction of thiopental with esomeprazole in critically ill patients.

Authors:  Amélie Marsot; Françoise Goirand; Nadine Milési; Monique Dumas; Audrey Boulamery; Nicolas Simon
Journal:  Eur J Clin Pharmacol       Date:  2013-05-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.